Putting germs to the test
Speedy diagnostic tests are driving recession-resistant growth for this Midwest biotech firm.
 |
| Meridian's high-tech test kit will confirm this intruder to be E. coli. |
CINCINNATI (Fortune Small Business) -- One man's germ is another man's gem, or so it is for Bill Motto, the 67-year-old cofounder and executive chairman of Meridian Bioscience (VIVO), based in Cincinnati. Motto's company makes diagnostic kits for diseases ranging from hospital bacterial infections to the flu.
Meridian ranked No. 58 on last year's FSB 100 list of the fastest-growing small public companies, and sales of its kits keep rising as doctors scramble to diagnose and treat more and more threatening outbreaks. Revenues for fiscal 2007, ended in September, topped $123 million, up 13% from 2006, the fifth consecutive year of double-digit increases; net income jumped 46%, to $26.7 million.
Despite a soft economy, Meridian's profits for the first half of fiscal 2008, ended in March, rose 29% on a 15% bump in sales. Spurring growth is an expanded product lineup, now including rapid-test kits for E. coli infections and also for bacteria that can lead to stomach ulcers.
"They've got a terrific niche market," says Elliott Schlang, an analyst with Great Lakes Review, a unit of Soleil Securities, based in Cleveland.
Schlang, who holds Meridian stock, points out that the company can capitalize on the booming health-care sector without suffering a big negative that commonly bedevils its industry peers - shrinking reimbursements from insurers or the government. Why? Meridian's kits employ cutting-edge technology to provide fast, accurate diagnoses, making the tests a hit with doctors. And because the kits are inexpensive - they average just $6 apiece - the cost is included in the office-visit charge.
Meridian's biggest growth challenge going forward may be the weight of its own success. Profits are up almost fourfold since 2003. With revenues now topping $100 million, Schlang expects the heart-pounding 33% annual growth rate in earnings per share over the past few years to slow to a 22% rate for the next three to five years. 
-
Arson. Scrappers. Blackouts. It's part of business for the last tenant in Detroit's Packard Plant. More -
Inventing is the easy part. Marketing? Trickier. Experts tell how they'd advertise 5 hard-to-tout products. More -
Every restaurateur knows about Cursed Locations, the addresses where no venture survives. More -
Detroit's churches are plowing millions into redeveloping local housing and businesses. More -
Winepod attracted a wait list of eager buyers and millions from investors. Then came the recession. More
We've run a dinner theater for three decades. We've been operating at a loss for the last couple of years, and are unable to get a loan. We even closed for two months this summer to save money. We don't know what to do. More
Across the nation, the deepening economic downturn is fueling anxiety among everyday folks. See what's got them worried and how they're coping. More
Many of Bernie Madoff's victims wanted a piece of the felonious financier. This week they could get one: Hundreds of his and Ruth's possessions went up for auction Saturday and they fetched nearly $1 million, a lot more than expected. More
The recovery from the Great Recession has likely started. But many economists are worried about falling into another downturn. Here's what has them concerned. More
More Small Business
